Adobe settles DOJ lawsuit for $150 million but denies wrongdoing

Moneycontrol
Adobe will pay $150 million to settle a DOJ lawsuit regarding its subscription cancellation practices, without admitting fault.

Summary

Adobe has reached a $150 million settlement with the U.S. Department of Justice (DOJ) to resolve allegations concerning its subscription cancellation practices. The agreement includes a $75 million payment to the DOJ and $75 million in free services for affected customers. While settling, Adobe maintains it did not engage in any wrongdoing. The company will contact eligible customers for compensation after receiving court approval. The lawsuit centered around concerns that Adobe made it difficult for customers to cancel their subscriptions, leading to unwanted charges. This settlement aims to provide redress for those impacted by these practices and ensure more transparent cancellation processes in the future.

(Source:Moneycontrol)

New York Post

Costco class action lawsuit settlement could earn affected customers $500

The Philadelphia Inquirer

A property manager used rent price-setting algorithms that were banned in Philly last year, lawsuit says

Bloomberg Tax News

Union Sues EEOC Over Suspended Federal Worker Class Actions (1)

The Economic Times

How Oracle's 2012 court defeat became the heart of £270 million lawsuit against Microsoft

7NEWS Australia

Johnson & Johnson to pay $7.9 billion in landmark talc cancer settlement as Australian class action gathers pace

Natural News

Federal Judge Approves $1.5 Billion Copyright Settlement Against AI Company Anthropic

San Diego Union-Tribune

San Diego appeals court finds that license plate data collection alone is not harm

Charleston Post and Courier

Richland County to settle class-action case over inadequate care brought by mentally ill detainees

City A.M.

Trawlerman can overhaul Scandinavia for Goodwood gold

Electrek

Tesla partly settles racism lawsuit as hundreds of workers press on

Mint

UPI-linked PF claim settlement facility rollout delayed: Expected launch timeline and key benefits for EPFO members

Bnn Bloomberg

Canadians may be eligible for a piece of this class-action involving a drug used to treat depression, schizophrenia

CP24 Toronto

Canadians may be eligible for a piece of this class-action involving a drug used to treat depression, schizophrenia

The Globe and Mail

Deadline nears to file claim in class-action lawsuit over drug Rexulti

BayToday

Deadline fast approaching for Canadians to file claim in class-action drug suit